pyrroles has been researched along with Candidiasis in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (14.29) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (71.43) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dong, X; Fu, N; Hu, Y; Lv, X; Wang, L; Weng, L; Xue, L; Yang, D; Yang, N | 1 |
Chen, Y; Gao, XM; Gong, FY; Gong, Z; Li, ZJ; Ma, SY; Zhou, Z | 1 |
Akasaka, T; Ishida, H; Kato, S; Kawamoto, Y; Mori, K | 1 |
Jasrai, YT; Kumar, SP; Pandya, HA | 1 |
Bilitewski, U; Burakowska, A; Buschart, A | 1 |
Apuzzo, G; Artico, M; Costi, R; Di Santo, R; Massa, S; Retico, A; Simonetti, G; Strippoli, V | 1 |
Fraser-Smith, EB; Matthews, TR | 1 |
7 other study(ies) available for pyrroles and Candidiasis
Article | Year |
---|---|
A lipase-responsive antifungal nanoplatform for synergistic photodynamic/photothermal/pharmaco-therapy of azole-resistant Candida albicans infections.
Topics: Animals; Antifungal Agents; Azoles; Candida albicans; Candidiasis; Drug Resistance, Fungal; Ethylene Glycols; Fluconazole; Ketones; Lasers; Lipase; Mice; Nanoparticles; Photochemotherapy; Phototherapy; Polyesters; Pyrroles | 2019 |
A study on the risk of fungal infection with tofacitinib (CP-690550), a novel oral agent for rheumatoid arthritis.
Topics: Administration, Oral; Adult; Animals; Arthritis, Rheumatoid; Candida albicans; Candidiasis; Disease Susceptibility; Female; Humans; Mice, Inbred BALB C; Neutrophil Activation; Neutrophils; Phagocytosis; Piperidines; Pyrimidines; Pyrroles; Risk Factors | 2017 |
Gastric candidiasis developing after administration of potassium-competitive acid blocker.
Topics: Candidiasis; Humans; Male; Middle Aged; Pyrroles; Stomach Diseases; Sulfonamides | 2019 |
Applications of Receptor- and Ligand-based Models in Inverse Docking Experiments: Recognition of Dihydrofolate Reductase Using 7,8-Dialkyl- 1,3-Diaminopyrrolo[3,2-f]Quinazolines.
Topics: Candida albicans; Candidiasis; Folic Acid Antagonists; Humans; Ligands; Molecular Docking Simulation; Protein Binding; Pyrroles; Quinazolines; Structure-Activity Relationship; Tetrahydrofolate Dehydrogenase | 2016 |
The fungicide fludioxonil antagonizes fluconazole activity in the human fungal pathogen Candida albicans.
Topics: Antifungal Agents; ATP-Binding Cassette Transporters; Candida albicans; Candidiasis; Cell Proliferation; Dioxoles; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Fungicides, Industrial; Gene Expression Regulation, Fungal; Histidine Kinase; Humans; Membrane Transport Proteins; Microbial Sensitivity Tests; Protein Kinases; Pyrroles; Rhodamines | 2012 |
Antifungal agents. 9. 3-Aryl-4-[alpha-(1H-imidazol-1-yl)arylmethyl]pyrroles: a new class of potent anti-Candida agents.
Topics: Adult; Animals; Antifungal Agents; Candida; Candida albicans; Candidiasis; Drug Resistance, Microbial; Female; Humans; Hydrogen-Ion Concentration; Imidazoles; Male; Molecular Structure; Pyrroles; Rabbits; Structure-Activity Relationship | 1995 |
Effect of ketorolac on Candida albicans ocular infection in rabbits.
Topics: Animals; Candidiasis; Dexamethasone; Endophthalmitis; Ketorolac Tromethamine; Pyrroles; Rabbits; Tolmetin; Tromethamine | 1987 |